176 related articles for article (PubMed ID: 18393881)
1. Scope and limitations of the co-drug approach to topical drug delivery.
Lau WM; White AW; Gallagher SJ; Donaldson M; McNaughton G; Heard CM
Curr Pharm Des; 2008; 14(8):794-802. PubMed ID: 18393881
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of ocular drug penetration.
Sasaki H; Yamamura K; Mukai T; Nishida K; Nakamura J; Nakashima M; Ichikawa M
Crit Rev Ther Drug Carrier Syst; 1999; 16(1):85-146. PubMed ID: 10099899
[TBL] [Abstract][Full Text] [Related]
3. Prodrug strategy for enhancing drug delivery via skin.
Fang JY; Leu YL
Curr Drug Discov Technol; 2006 Sep; 3(3):211-24. PubMed ID: 17311566
[TBL] [Abstract][Full Text] [Related]
4. Formulation design for topical drug and nanoparticle treatment of skin disease.
Raphael AP; Garrastazu G; Sonvico F; Prow TW
Ther Deliv; 2015 Feb; 6(2):197-216. PubMed ID: 25690087
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in ocular drug delivery.
Achouri D; Alhanout K; Piccerelle P; Andrieu V
Drug Dev Ind Pharm; 2013 Nov; 39(11):1599-617. PubMed ID: 23153114
[TBL] [Abstract][Full Text] [Related]
6. Prodrugs: design and clinical applications.
Rautio J; Kumpulainen H; Heimbach T; Oliyai R; Oh D; Järvinen T; Savolainen J
Nat Rev Drug Discov; 2008 Mar; 7(3):255-70. PubMed ID: 18219308
[TBL] [Abstract][Full Text] [Related]
7. Codrug: an efficient approach for drug optimization.
Das N; Dhanawat M; Dash B; Nagarwal RC; Shrivastava SK
Eur J Pharm Sci; 2010 Dec; 41(5):571-88. PubMed ID: 20888411
[TBL] [Abstract][Full Text] [Related]
8. Recent Advances in Topical Ocular Drug Delivery.
Yellepeddi VK; Palakurthi S
J Ocul Pharmacol Ther; 2016 Mar; 32(2):67-82. PubMed ID: 26666398
[TBL] [Abstract][Full Text] [Related]
9. Research Techniques Made Simple: Drug Delivery Techniques, Part 1: Concepts in Transepidermal Penetration and Absorption.
Schmieder S; Patel P; Krishnamurthy K
J Invest Dermatol; 2015 Nov; 135(11):1-5. PubMed ID: 26548480
[No Abstract] [Full Text] [Related]
10. Biocompatible nanoparticles and vesicular systems in transdermal drug delivery for various skin diseases.
Carter P; Narasimhan B; Wang Q
Int J Pharm; 2019 Jan; 555():49-62. PubMed ID: 30448309
[TBL] [Abstract][Full Text] [Related]
11. Advances in the use of prodrugs for drug delivery to the eye.
Taskar P; Tatke A; Majumdar S
Expert Opin Drug Deliv; 2017 Jan; 14(1):49-63. PubMed ID: 27441817
[TBL] [Abstract][Full Text] [Related]
12. Recent advances and development in epidermal and dermal drug deposition enhancement technology.
Iqbal B; Ali J; Baboota S
Int J Dermatol; 2018 Jun; 57(6):646-660. PubMed ID: 29430629
[TBL] [Abstract][Full Text] [Related]
13. A look at emerging delivery systems for topical drug products.
Fireman S; Toledano O; Neimann K; Loboda N; Dayan N
Dermatol Ther; 2011; 24(5):477-88. PubMed ID: 22353154
[TBL] [Abstract][Full Text] [Related]
14. The co-drug of conjugated hydroquinone and azelaic acid to enhance topical skin targeting and decrease penetration through the skin.
Hsieh PW; Al-Suwayeh SA; Fang CL; Lin CF; Chen CC; Fang JY
Eur J Pharm Biopharm; 2012 Jun; 81(2):369-78. PubMed ID: 22469554
[TBL] [Abstract][Full Text] [Related]
15. Molecular design for enhancement of ocular penetration.
Shirasaki Y
J Pharm Sci; 2008 Jul; 97(7):2462-96. PubMed ID: 17918725
[TBL] [Abstract][Full Text] [Related]
16. Erbium-yttrium-aluminum-garnet laser irradiation ameliorates skin permeation and follicular delivery of antialopecia drugs.
Lee WR; Shen SC; Aljuffali IA; Li YC; Fang JY
J Pharm Sci; 2014 Nov; 103(11):3542-3552. PubMed ID: 25187109
[TBL] [Abstract][Full Text] [Related]
17. [Urea in topical therapy of skin diseases--principles and use].
Wohlrab WA
Z Arztl Fortbild (Jena); 1993 Aug; 87(8):643-50. PubMed ID: 8379203
[No Abstract] [Full Text] [Related]
18. Liposomes and niosomes as topical drug delivery systems.
Choi MJ; Maibach HI
Skin Pharmacol Physiol; 2005; 18(5):209-19. PubMed ID: 16015019
[TBL] [Abstract][Full Text] [Related]
19. Efficacy study of vesicular gel containing methotrexate and menthol combination on parakeratotic rat skin model.
Nagle A; Goyal AK; Kesarla R; Murthy RR
J Liposome Res; 2011 Jun; 21(2):134-40. PubMed ID: 20557280
[TBL] [Abstract][Full Text] [Related]
20. The Clinical Relevance and Therapeutic Benefit of Established Active Ingredients Incorporated into Advanced Foam Vehicles: Vehicle Characteristics Can Influence and Improve Patient Outcomes.
Del Rosso JQ; Kircik LH; Zeichner J; Stein Gold L
J Drugs Dermatol; 2019 Feb; 18(2s):s100-s107. PubMed ID: 30811153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
